• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌脑转移:危险因素、发病率及趋化因子的潜在作用

Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines.

作者信息

Mongan John P, Fadul Camilo E, Cole Bernard F, Zaki Bassem I, Suriawinata Arief A, Ripple Gregory H, Tosteson Tor D, Pipas J Marc

机构信息

Department of Internal Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.

出版信息

Clin Colorectal Cancer. 2009 Apr;8(2):100-5.

PMID:19739271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3909497/
Abstract

BACKGROUND

Brain metastases from colorectal cancer (CRC) are uncommon. There has been relatively little published on the host and tumor factors that might lead to this clinical scenario. We reviewed all cases of brain metastases from CRC at Dartmouth-Hitchcock Medical Center over a more than 20-year period to establish incidence and to identify patient and cancer characteristics which were associated with their development.

PATIENTS AND METHODS

We present a retrospective review of 39 confirmed cases of brain metastases from CRC diagnosed between 1984 and 2006. Immunohistochemical staining for CXCR4 was performed on all available brain metastasis biopsy specimens.

RESULTS

The incidence of brain metastases from CRC was 2.3%. Left-sided primary colon tumors predominated. The majority of patients had pulmonary metastases at the time brain metastases were identified, and those with preexisting pulmonary metastases had progression of that disease. All patients were symptomatic from brain metastases, and the cerebellum was the most common area of brain involvement. Immunohistochemical analysis confirmed strong expression of CXCR4 in all brain metastases sampled.

CONCLUSION

The incidence of brain metastases from CRC is low. Primary tumor in the left colon, long-standing pulmonary metastases, especially those with recent progression, and CXCR4 expression by tumor cells are all associated with increased risk of brain metastases. Increased survival among patients with metastatic CRC will likely result in an increased incidence of brain metastases. Further characterization of the role of tumor and host factors might yield better insight into the development, and potentially the prevention, of this devastating situation.

摘要

背景

结直肠癌(CRC)脑转移并不常见。关于可能导致这种临床情况的宿主和肿瘤因素的报道相对较少。我们回顾了达特茅斯-希区柯克医疗中心20多年来所有结直肠癌脑转移病例,以确定发病率,并确定与其发生相关的患者和癌症特征。

患者与方法

我们对1984年至2006年间确诊的39例经证实的结直肠癌脑转移病例进行了回顾性研究。对所有可用的脑转移活检标本进行CXCR4免疫组织化学染色。

结果

结直肠癌脑转移的发生率为2.3%。左侧原发性结肠肿瘤占主导。大多数患者在发现脑转移时已有肺转移,且那些已有肺转移的患者出现了该疾病的进展。所有患者均有脑转移症状,小脑是最常受累的脑区。免疫组织化学分析证实,所有采样的脑转移灶中CXCR4均呈强表达。

结论

结直肠癌脑转移的发生率较低。左半结肠癌、长期存在的肺转移,尤其是近期进展的肺转移以及肿瘤细胞CXCR4表达均与脑转移风险增加相关。转移性结直肠癌患者生存率的提高可能会导致脑转移发生率增加。进一步明确肿瘤和宿主因素的作用可能会更好地了解这种灾难性情况的发生,甚至可能预防其发生。

相似文献

1
Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines.结直肠癌脑转移:危险因素、发病率及趋化因子的潜在作用
Clin Colorectal Cancer. 2009 Apr;8(2):100-5.
2
Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines.结直肠癌脑转移:危险因素、发病率及趋化因子的潜在作用
Clin Colorectal Cancer. 2009 Mar;8(2):100-5. doi: 10.3816/CCC.2009.n.016.
3
Changing patterns of bone and brain metastases in patients with colorectal cancer.结直肠癌患者骨转移和脑转移模式的变化
Clin Colorectal Cancer. 2005 Jul;5(2):108-13. doi: 10.3816/ccc.2005.n.022.
4
Risk factors for brain metastases in patients with metastatic colorectal cancer.转移性结直肠癌患者发生脑转移的危险因素。
Acta Oncol. 2017 May;56(5):639-645. doi: 10.1080/0284186X.2017.1290272. Epub 2017 Feb 22.
5
Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.基质细胞衍生因子-1和CXCR4在结直肠癌中的表达促进肝转移。
Cancer Biomark. 2015;15(6):869-79. doi: 10.3233/CBM-150531.
6
Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.趋化因子受体CXCR4在黑色素瘤和结直肠癌肝转移患者中的表达及其与疾病预后的关系。
Ann Surg. 2006 Jul;244(1):113-20. doi: 10.1097/01.sla.0000217690.65909.9c.
7
Resection of brain metastases from colorectal carcinoma in 73 patients.73例结直肠癌脑转移瘤切除术
Cancer. 1999 Apr 15;85(8):1677-85. doi: 10.1002/(sici)1097-0142(19990415)85:8<1677::aid-cncr6>3.0.co;2-c.
8
The incidence and outcome of brain metastases after liver resection for colorectal cancer metastases.结直肠癌肝转移术后脑转移的发生率和转归。
Colorectal Dis. 2012 Jun;14(6):721-6. doi: 10.1111/j.1463-1318.2011.02762.x.
9
[Brain metastases occurring more often in colorectal carcinoma].
Ned Tijdschr Geneeskd. 2014;158:A7256.
10
Colorectal cancer liver metastases - a population-based study on incidence, management and survival.结直肠癌肝转移-基于人群的发病率、治疗和生存研究。
BMC Cancer. 2018 Jan 15;18(1):78. doi: 10.1186/s12885-017-3925-x.

引用本文的文献

1
Incidence, demographics, and survival of patients with brain metastases from stage IV colorectal cancer: a population-based study from 2013 to 2023.IV期结直肠癌脑转移患者的发病率、人口统计学特征及生存率:一项基于人群的2013年至2023年研究。
J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05107-9.
2
Progress in personalized immunotherapy for patients with brain metastasis.脑转移患者个性化免疫治疗的进展。
NPJ Precis Oncol. 2025 Jan 29;9(1):31. doi: 10.1038/s41698-025-00812-0.
3
GNG2 inhibits brain metastases from colorectal cancer via PI3K/AKT/mTOR signaling pathway.GNG2通过PI3K/AKT/mTOR信号通路抑制结直肠癌脑转移。
Sci Rep. 2025 Jan 13;15(1):1787. doi: 10.1038/s41598-025-85592-0.
4
Crosstalk Between the Nervous System and Colorectal Cancer.神经系统与结直肠癌之间的相互作用
Neurosci Bull. 2025 Jan;41(1):93-106. doi: 10.1007/s12264-024-01238-7. Epub 2024 Jun 16.
5
HER2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study.HER2 表达和结直肠癌脑转移瘤的基因组特征:HEROES 研究。
Br J Cancer. 2024 May;130(8):1316-1323. doi: 10.1038/s41416-023-02569-4. Epub 2024 Feb 12.
6
Frequency of seizures in patients with metastatic brain tumors.转移性脑肿瘤患者的癫痫发作频率。
Neurol Sci. 2023 Jul;44(7):2501-2507. doi: 10.1007/s10072-023-06695-y. Epub 2023 Feb 20.
7
Powerful anti-colon cancer effect of modified nanoparticle-mediated IL-15 immunogene therapy through activation of the host immune system.通过激活宿主免疫系统,修饰纳米颗粒介导的 IL-15 免疫基因治疗对结肠癌具有强大的抗癌作用。
Theranostics. 2018 Jun 6;8(13):3490-3503. doi: 10.7150/thno.24157. eCollection 2018.
8
Metastatic colon cancer presenting as pituitary mass.以垂体肿块形式出现的转移性结肠癌。
Gastrointest Cancer Res. 2013 Sep;6(5-6):152-5.
9
Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data.从 2007 年美国癌症发病率数据估算转移性脑肿瘤的终生发病情况。
Neuro Oncol. 2012 Sep;14(9):1171-7. doi: 10.1093/neuonc/nos152. Epub 2012 Aug 16.
10
microRNA expression profiles in human colorectal cancers with brain metastases.伴有脑转移的人类结直肠癌中的微小RNA表达谱
Oncol Lett. 2012 Feb;3(2):346-350. doi: 10.3892/ol.2011.497. Epub 2011 Nov 29.

本文引用的文献

1
Cancer statistics, 2008.2008年癌症统计数据。
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
2
Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.血管内皮生长因子C、趋化因子受体CXCR4的表达与结直肠癌淋巴结转移之间的关联
Oncology. 2006;71(3-4):204-11. doi: 10.1159/000106070. Epub 2007 Jul 19.
3
Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.CXC趋化因子受体4和血管内皮生长因子蛋白的过表达可预测II-III期结直肠癌患者早期远处复发。
Clin Cancer Res. 2006 May 1;12(9):2795-803. doi: 10.1158/1078-0432.CCR-05-2142.
4
Chemokines and cancer.趋化因子与癌症
Int J Cancer. 2006 Nov 1;119(9):2026-9. doi: 10.1002/ijc.22024.
5
Brain metastases: epidemiology and pathophysiology.脑转移瘤:流行病学与病理生理学
J Neurooncol. 2005 Oct;75(1):5-14. doi: 10.1007/s11060-004-8093-6.
6
Changing patterns of bone and brain metastases in patients with colorectal cancer.结直肠癌患者骨转移和脑转移模式的变化
Clin Colorectal Cancer. 2005 Jul;5(2):108-13. doi: 10.3816/ccc.2005.n.022.
7
Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.趋化因子受体CXCR4在结直肠癌患者中的表达增加了复发风险和降低生存率。
J Clin Oncol. 2005 Apr 20;23(12):2744-53. doi: 10.1200/JCO.2005.07.078.
8
Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer.趋化因子受体CXCR4和CCR7对人结直肠癌转移行为的影响。
Clin Cancer Res. 2005 Mar 1;11(5):1743-50. doi: 10.1158/1078-0432.CCR-04-1195.
9
Cancer and the chemokine network.癌症与趋化因子网络
Nat Rev Cancer. 2004 Jul;4(7):540-50. doi: 10.1038/nrc1388.
10
Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.在治疗过程中,随着氟尿嘧啶-亚叶酸、伊立替康和奥沙利铂的应用,晚期结直肠癌患者的生存率有所提高。
J Clin Oncol. 2004 Apr 1;22(7):1209-14. doi: 10.1200/JCO.2004.11.037.